BioLargo to Present Its Cellinity Battery Technology at LD Micro Main Event XIX in San Diego on Monday, October 20, at 2:00 p.m. PT
Rhea-AI Summary
BioLargo (OTCQX:BLGO) will present its Cellinity battery technology at LD Micro Main Event XIX on Monday, October 20, 2025 at 2:00 p.m. PT at the Hotel del Coronado in San Diego.
Management says Cellinity is a battery storage solution for AI infrastructure that eliminates the need for rare earth elements. The company emphasizes applications in AI data centers and grid-scale storage and notes related capabilities in water reuse, PFAS remediation, odor/VOC control, and on-site energy storage. A live webcast is available at https://ldmicrocasts.com/#register.
The release includes a Safe Harbor statement about forward-looking expectations and refers investors to the company's SEC filings for risks.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, BLGO declined 0.54%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Cellinity is a breakthrough battery storage solution for AI infrastructure that eliminates the need for rare earth elements
WESTMINSTER, CA, CA / ACCESS Newswire / October 14, 2025 / BioLargo, Inc. (OTCQX:BLGO), a cleantech innovator that develops and commercializes sustainable technologies, today announced that its management team will present at the LD Micro Main Event XIX at the Hotel del Coronado in San Diego, California, on Monday, October 20, at 2:00 p.m. Pacific Time.
For access to the webcast presentation please visit: https://ldmicrocasts.com/#register
Dennis P. Calvert, BioLargo CEO, commented, "Our primary focus is on advancing safer, more efficient batteries to support the rapid growth of AI infrastructure and grid scale applications. At the same time, we're leveraging our proven expertise to deliver additional solutions that address key challenges for data centers and industry - including water reuse, PFAS remediation, and more".
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. Its core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy efficiency and safe on-site energy storage, and control infections and infectious disease. BioLargo's approach is to invent or acquire novel technologies, develop them into commercial offerings, and extend their reach through licensing and channel partnerships to maximize their impact. Visit www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, those regarding BioLargo's ("the Company") expectations about anticipated revenue and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from those expressed or implied. More information on these risks and other potential factors is included in the Company's filings with the SEC, including its most recent Form 10-K, Form 10-Q, and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
FAQ
When will BioLargo (BLGO) present Cellinity at LD Micro Main Event XIX?
How can I watch BioLargo's (BLGO) LD Micro presentation on October 20, 2025?
What is Cellinity battery technology that BioLargo (BLGO) will showcase?
What applications did BioLargo (BLGO) highlight for Cellinity on October 14, 2025?
Will BioLargo (BLGO) discuss other technologies at the LD Micro event?
Where can investors find risk disclosures related to BioLargo's (BLGO) forward-looking statements?
